Medivie Therapeutic Ltd (MDVI) — Long-term Investment Intensity

Latest as of December 2018: 11.6%

Medivie Therapeutic Ltd (MDVI) has a Long-term Investment Intensity of 11.6% as of December 2018. Long-term investments of ILA1.91 Million represent 11.6% of total assets of ILA16.50 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Medivie Therapeutic Ltd (MDVI) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

LT Investment Intensity

11.6%
LT Investments / Total Assets

Long-term Investments

ILA1.91 Million
ILA

Total Assets

ILA16.50 Million
ILA

Country

Israel
TA

Medivie Therapeutic Ltd Long-term Investment Intensity (2018–2018)

This chart shows how Medivie Therapeutic Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2018 to 2018. As of December 2018, the intensity stands at 11.6%, reflecting long-term investments of ILA1.91 Million against total assets of ILA16.50 Million ILA. Explore debt repayment capacity of Medivie Therapeutic Ltd to assess how comfortably operating cash covers total debt obligations.

Annual Long-term Investment Intensity for Medivie Therapeutic Ltd (2018–2018)

The table below presents the year-by-year Long-term Investment Intensity for Medivie Therapeutic Ltd from 2018 to 2018, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Medivie Therapeutic Ltd (MDVI) total market value.

Year LT Investment Intensity LT Investments (ILA) Total Assets Change (pp)
2018 11.6% ILA1.91 Million ILA16.50 Million
pp = percentage points